moxifloxacin has been researched along with omadacycline in 7 studies
| Studies (moxifloxacin) | Trials (moxifloxacin) | Recent Studies (post-2010) (moxifloxacin) | Studies (omadacycline) | Trials (omadacycline) | Recent Studies (post-2010) (omadacycline) |
|---|---|---|---|---|---|
| 3,157 | 552 | 1,690 | 102 | 12 | 101 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 4 (57.14) | 24.3611 |
| 2020's | 3 (42.86) | 2.80 |
| Authors | Studies |
|---|---|
| Hammerschlag, MR; Huerta, N; Kohlhoff, SA | 1 |
| Das, AF; Eckburg, PB; Garrity-Ryan, L; Gonong, JR; Kirsch, C; Loh, E; Madej, A; Manley, A; McGovern, PC; Mitha, I; Nseir, W; Popescu, M; Steenbergen, JN; Stets, R; Tzanis, E | 1 |
| Chitra, S; Curran, M; Kirsch, C; Manley, A; McGovern, PC; Noble, R; Ramirez, JA; Tzanis, E | 1 |
| Darpo, B; Tanaka, SK; Tzanis, E; Xue, H | 1 |
| Curran, M; Das, AF; Eckburg, PB; Garrity-Ryan, L; Kirsch, C; Manley, A; McGovern, PC; Steenbergen, JN; Torres, A; Tzanis, E | 1 |
| LaPensee, K; Lodise, TP; Mistry, R; Young, K | 1 |
| Chitra, S; McGovern, P; Pai, MP; Wilcox, M | 1 |
5 trial(s) available for moxifloxacin and omadacycline
| Article | Year |
|---|---|
Omadacycline for Community-Acquired Bacterial Pneumonia.
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacteria; Community-Acquired Infections; Double-Blind Method; Drug Administration Schedule; Female; Hospitalization; Humans; Infusions, Intravenous; Intention to Treat Analysis; Male; Middle Aged; Moxifloxacin; Pneumonia, Bacterial; Tetracyclines | 2019 |
Early Clinical Response in Community-acquired Bacterial Pneumonia: From Clinical Endpoint to Clinical Practice.
Topics: Adult; Anti-Bacterial Agents; Community-Acquired Infections; Double-Blind Method; Drug Approval; Humans; Internationality; Moxifloxacin; Pneumonia, Bacterial; Predictive Value of Tests; Tetracyclines | 2019 |
Randomized, Double-Blind, Placebo- and Positive-Controlled Crossover Study of the Effects of Omadacycline on QT/QTc Intervals in Healthy Subjects.
Topics: Adult; Anti-Bacterial Agents; Cross-Over Studies; Dose-Response Relationship, Drug; Double-Blind Method; Electrocardiography; Female; Healthy Volunteers; Heart Rate; Humans; Long QT Syndrome; Male; Moxifloxacin; Tetracyclines | 2019 |
Omadacycline vs moxifloxacin in adults with community-acquired bacterial pneumonia.
Topics: Administration, Intravenous; Aged; Anti-Bacterial Agents; Community-Acquired Infections; Double-Blind Method; Female; Humans; Male; Middle Aged; Moxifloxacin; Pneumonia, Bacterial; Tetracyclines | 2021 |
Safety and efficacy of omadacycline by body mass index in patients with community-acquired bacterial pneumonia: Subanalysis from a randomized controlled trial.
Topics: Adult; Aged; Body Mass Index; Community-Acquired Infections; Drug Dosage Calculations; Female; Humans; Infusions, Intravenous; Male; Middle Aged; Moxifloxacin; Pneumonia, Bacterial; Safety; Tetracyclines; Treatment Outcome | 2021 |
2 other study(ies) available for moxifloxacin and omadacycline
| Article | Year |
|---|---|
Topics: Anti-Bacterial Agents; Azithromycin; Cell Line; Chlamydial Pneumonia; Chlamydophila pneumoniae; Doxycycline; Humans; Levofloxacin; Microbial Sensitivity Tests; Moxifloxacin; Tetracyclines | 2019 |
Decision Analysis: Omadacycline Relative to Moxifloxacin Among Hospitalized Community-Acquired Bacterial Pneumonia Patients at Risk of Clostridioides difficile Infection.
Topics: Administration, Intravenous; Adult; Anti-Bacterial Agents; Clostridium Infections; Community-Acquired Infections; Hospitalization; Humans; Moxifloxacin; Pneumonia, Bacterial; Tetracyclines | 2021 |